Core Points - The company Zhiyang Innovation announced that several board members and executives plan to reduce their shareholdings due to personal financial needs, with specific amounts and percentages outlined [1] Summary by Category Shareholding Reduction - Board member Chen Xiaojun intends to reduce holdings by up to 500,000 shares (0.22% of total share capital) [1] - Board member Sun Peixiang plans to reduce holdings by up to 270,000 shares (0.12% of total share capital) [1] - Board member Zhang Wanzheng aims to reduce holdings by up to 100,000 shares (0.04% of total share capital) [1] - Vice President Bao Chunfei intends to reduce holdings by up to 160,000 shares (0.07% of total share capital) [1] - Vice President Wang Shutang plans to reduce holdings by up to 100,000 shares (0.04% of total share capital) [1] - Vice President Hu Zhikuan aims to reduce holdings by up to 48,000 shares (0.02% of total share capital) [1] - CFO Hu Xuehai intends to reduce holdings by up to 30,000 shares (0.01% of total share capital) [1] Timeline and Method - The reduction period is set from November 28, 2025, to February 27, 2026, with the specific price, quantity, and method to be determined based on market conditions [1] Impact on Company - The reducing shareholders are not controlling shareholders or actual controllers, and the planned reductions are not expected to significantly impact the company's governance structure or ongoing operations [1]

Core Viewpoint - Honghe Technology (SH 603256) announced a plan for major shareholders SHARP TONE and UNICORN ACE to reduce their holdings by up to 17,594,550 shares, representing 2% of the company's total equity, due to funding needs [1] Group 1: Shareholder Actions - The reduction plan will be executed through block trading within three months after the announcement, starting 15 trading days post-announcement [1] - As of the announcement date, shareholders have already reduced their holdings by approximately 2.8 million shares, which is 0.32% of the total equity [1] Group 2: Company Financials - For the year 2024, the revenue composition of Honghe Technology is as follows: electronic-grade glass fiber cloth accounts for 93.47%, electronic-grade glass fiber yarn for 6.44%, and other businesses for 0.1% [1] - The current market capitalization of Honghe Technology is 28.5 billion yuan [1]

Core Viewpoint - The shareholders of Xiangteng New Materials have decided to terminate their share reduction plan ahead of schedule, which was initially set to reduce a total of 2.0606 million shares, accounting for 3% of the total share capital [1] Summary by Relevant Sections - **Shareholder Actions** - Shareholders Xianghe Yongyuan, Shanghai Longxin, Nanshan Yongquan, and Shanghai Yongyue planned to reduce their holdings by up to 2.0606 million shares from September 8 to December 7, 2025 [1] - As of November 6, these shareholders had reduced their holdings by 2.0010 million shares, representing 2.91% of the total share capital [1] - **Share Price Information** - The reduction in shareholding occurred at a price range of 26.58 to 31.59 yuan per share [1] - **Impact on Company** - The share reduction does not violate any relevant regulations and will not lead to a change in company control, thus having no significant impact on the company's operations [1]

Core Viewpoint - Trina Solar's major shareholder, Jiangsu Youze Venture Capital Group Co., Ltd., has completed a share reduction plan, selling 12,474,897 shares, which is 0.5724% of the company's total share capital, between September 5 and November 3, 2025, at prices ranging from 17.61 to 21.82 CNY per share, totaling approximately 252.43 million CNY [1][2]. Group 1: Share Reduction Details - The share reduction plan was first disclosed on August 12, 2025 [2]. - The total number of shares reduced was 12,474,897 [2]. - The reduction period spanned from September 5 to November 3, 2025 [2]. - The shares were sold through centralized bidding [2]. - The price range for the shares sold was between 17.61 and 21.82 CNY per share [2]. - The total amount raised from the share reduction was 252,429,250.73 CNY [2]. - The share reduction plan has been completed [2]. - The current holding of Jiangsu Youze Venture Capital is 0 shares, representing 0% of the total share capital [2]. Group 2: Shareholder Information - Jiangsu Youze Venture Capital is a major shareholder and an action-in-concert party with the actual controller, Gao Jifan [3]. - Gao Jifan controls 35.61% of the company’s shares, with direct holdings of 12.12% and indirect holdings through controlled entities [4]. - The company went public on June 10, 2020, with an initial public offering of 310,200,000 shares at a price of 8.16 CNY per share [4]. Group 3: Financial Performance - In 2024, Trina Solar reported revenues of 80.28 billion CNY, a year-on-year decrease of 29.21%, and a net loss attributable to shareholders of 3.44 billion CNY [6]. - For the first half of 2025, the company achieved revenues of 31.06 billion CNY, down 27.72% year-on-year, with a net loss of 2.92 billion CNY [7].

Group 1 - The major shareholder Shenzhen Lefeng Investment Management Co., Ltd. reduced its stake in Guangzhou Dayilong Packaging Machinery Co., Ltd. by 3.67 million shares, accounting for 1.85% of the total share capital, bringing its ownership down from 10% to 8.15% [2] - The total reduction plan was completed, with a total of 5.97 million shares sold, representing 3% of the company's total share capital, and this action complies with relevant laws and regulations [2] - The company was established in December 1998, with a registered capital of 1.99 billion RMB, and its main business is the production and sales of food and packaging machinery [2] Group 2 - The company's revenue for 2022, 2023, 2024, and the first three quarters of 2025 were 1.148 billion RMB, 1.285 billion RMB, 1.521 billion RMB, and 1.335 billion RMB, showing year-on-year growth of 8.02%, 11.89%, 18.38%, and 38.95% respectively [3] - The net profit attributable to the parent company for the same periods were 22.35 million RMB, 46.62 million RMB, 69.79 million RMB, and 103 million RMB, with year-on-year growth rates of 143.37%, 108.59%, 49.69%, and 146.16% respectively [3] - The company's asset-liability ratios for the same periods were 65.59%, 68.75%, 71.88%, and 75.09% [3]

Core Viewpoint - The major shareholder, Guoshou Chengda, plans to reduce its stake in Huaxi Biological Technology Co., Ltd. by up to 9,633,564 shares, representing a maximum of 2.00% of the total share capital, through centralized bidding and block trading methods [3][11]. Shareholder Information - As of the announcement date, Guoshou Chengda directly holds 28,936,504 shares of Huaxi Biological, accounting for 6.01% of the total share capital [2][4]. Reduction Plan Details - The reduction plan allows for a maximum of 9,633,564 shares to be sold, with a maximum of 4,816,782 shares through centralized bidding and 4,816,782 shares through block trading, within a period from November 26, 2025, to February 23, 2026 [3][11]. - The reduction will be adjusted in case of any changes in share capital due to stock dividends, capital increases, or buybacks [3][11]. Commitment and Compliance - Guoshou Chengda has made commitments regarding the holding period and reduction intentions, stating that it will not transfer shares within 36 months from the listing date [6][7]. - The company will comply with relevant laws and regulations during the reduction process, including pre-disclosure of the reduction plan [9][10].

Core Viewpoint - The announcement details a share reduction plan by a significant shareholder of Jiangxi Hongbo New Materials Co., Ltd., indicating a potential decrease in shareholding and its implications for the company’s stock structure and governance [2][3][11]. Shareholder Holding Situation - Newyu Baolong Project Investment Center (Limited Partnership) holds 27,781,546 shares, representing 4.27% of the company's total shares [2]. Reduction Plan Details - Newyu Baolong plans to reduce its holdings by up to 19,500,000 shares, not exceeding 3.00% of the total share capital, within three months starting from November 27, 2025, through centralized bidding and/or block trading [3][5]. Shareholder Commitment - The shareholder has made commitments regarding the holding period and conditions for share reduction, including a prohibition on transferring shares within 12 months of the stock's listing and maintaining a minimum selling price [6][7]. Compliance with Regulations - The reduction plan complies with relevant laws and regulations, ensuring that it does not lead to a change in control of the company [11][12]. Risk Factors - The implementation of the reduction plan carries uncertainties related to market conditions and share price, which may affect the timing and quantity of shares sold [10].

Core Viewpoint - China Life Chengda plans to reduce its holdings in Huaxi Biological shares by up to 9.6336 million shares, representing no more than 2% of Huaxi Biological's total share capital [2][5]. Group 1: Shareholding and Reduction Plan - China Life Chengda, a private equity investment company under China Life, currently holds 28.9365 million shares of Huaxi Biological, accounting for 6.01% of the total share capital, making it the second-largest shareholder [5]. - The planned reduction will occur through centralized bidding and block trading, with a maximum of 1% of shares to be sold via each method [2]. - The reduction period is set for three months, starting from 15 trading days after the announcement, specifically from November 26, 2025, to February 23, 2026 [2]. Group 2: Recent Performance and Previous Reductions - Huaxi Biological's performance has been declining, with a reported revenue of 3.163 billion yuan for the first three quarters of 2025, a year-on-year decrease of 18.36%, and a net profit of 252 million yuan, down 30.29% year-on-year [6]. - Prior to this announcement, China Life Chengda had already reduced its holdings by 5.4968 million shares between October 31, 2024, and November 12, 2024, at a price range of 59.28 to 68.1 yuan per share, which represented a reduction of 1.14% [6]. - As of November 4, 2025, Huaxi Biological's stock price closed at 52.05 yuan per share, giving it a market capitalization of 25.1 billion yuan [9].

九号公司公告，存托凭证持有人Hctech III L.P.目前持有公司存托凭证1251.97万份，占1.75%，计划于 2025年11月27日～2025年12月31日期间，通过大宗交易方式减持不超过27.6万份，占公司存托凭证总数 的0.04%。本次减持因自身资金需求，不涉及公司实际控制人、董事及高管，亦不影响公司控制权及持 续经营。 ...

Core Viewpoint - Ningbo Zhongbai announced that shareholder Zhang Jiangbo holds 22,627,869 shares, accounting for 10.09% of the total share capital, and is not a controlling shareholder or actual controller of the company [1] Shareholder Reduction Plan - Due to personal funding needs and project investments, shareholder Zhang Jiangbo plans to reduce holdings by up to 2,240,000 shares, which represents no more than 1% of the company's total shares [1] - The reduction period is set for three months starting from 15 trading days after the announcement of the reduction plan [1]